Showing results (61-70 of 107) with videos related to
Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2007
American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myelomaRobert A Kyle, Gary C Yee, Mark R Somerfield, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2018
Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline UpdateKenneth Anderson, Nofisat Ismaila, Patrick J Flynn, et al.Cancer Medicine|October 13, 2020
Continuous lenalidomide and low-dose dexamethasone in patients with transplant-ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patientsAndrew Belch, Nizar Bahlis, Darrell White, et al.Leukemia & Lymphoma|February 26, 2008
Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myelomaPaul Richardson, Constantine Mitsiades, Kathleen Colson, et al.Seminars in Oncology|April 30, 2003
Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaMorie A Gertz, Athanasios Anagnostopoulos, Kenneth Anderson, et al.Molecular Pharmacology|April 6, 2022
Influence of Tyrosine Kinase Inhibition on Organic Anion Transporting Polypeptide 1B3-Mediated UptakeVusumuzi N Hove, Kenneth Anderson, Elizabeth R Hayden, et al.Implementation Science : IS|August 31, 2023
A cluster randomised controlled trial, process and economic evaluation of quality improvement collaboratives aligned to a national audit to improve the care for people with diabetes (EQUIPD): study protocolMichael Sykes, Bethan Copsey, Tracy Finch, et al.Blood Cancer Journal|August 1, 2023
Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panelNoopur Raje, Kenneth Anderson, Hermann Einsele, et al.Oncology (Williston Park, N.Y.)|June 4, 2010
Tailoring treatment for multiple myeloma patients with relapsed and refractory diseasePaul G Richardson, Jacob Laubach, Constantine Mitsiades, et al.Transfusion|November 9, 2002
Racial and ethnic composition of volunteer cord blood donors: comparison with volunteer unrelated marrow donorsKaren K Ballen, Julie Hicks, Bernie Dharan, et al.Pageof 11